Discover how ChestPal is redefining respiratory diagnosis through an AI-powered smart stethoscope. Co-founders Helena and Steve share the personal story and cutting-edge tech behind the device that detects crackles and wheezes with near-specialist accuracy — already validated in clinical trials and published in the European Respiratory Journal. With FDA clearance for professional use in the US and global ambitions to address respiratory mortality, ChestPal is poised to transform frontline healthcare and close diagnostic gaps worldwide.
ChestPal is an AI-powered respiratory health platform combining a handheld stethoscope with intelligent software to detect abnormal chest sounds - like wheeze and crackles - with clinical-grade accuracy. It empowers patients to track their lung health from home, while enabling clinicians to diagnose and monitor respiratory conditions remotely.Respiratory illness is a leading cause of GP visits, hospitalisations, and long-term health issues. ChestPal addresses this with a scalable, user-friendly solution that supports earlier diagnosis, reduces NHS pressure, and improves outcomes for asthma, COPD, bronchitis and more.Built with NHS clinicians and validated in UK pilots, ChestPal is CE-marked and ready for broad deployment. It’s not just a device - it’s a shift in how we deliver respiratory care.By making lung health monitoring accessible, accurate, and data-driven, ChestPal helps people breathe easier - wherever they are.
We believe that Brighton could be known for something epic - the epicentre for successful purpose-led startups. Our mission is to help evolve the local ecosystem and work with great people on great projects to achieve this.
Roll up your sleeves, and apply to join us.